MIDROPS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 17 Oct 2026)
What this means for you
Registered since 06 Oct 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 Oct 2030: the §8 & §9 renewal).
Record
- Serial number
- 88199169
- Registration number
- 6170100
- Mark type
- Word mark
- Filed
- 19 Nov 2018
- Published for opposition
- 04 Jun 2019
- Registered
- 06 Oct 2020
- Next maintenance filing
- §8 & §9 renewal, due by 06 Oct 2030 (grace period to 06 Apr 2031)
- Attorney of record
- Michael H. Smith
Goods and services
- Class 005 — Pharmaceuticals: Eye drops; Ophthalmic preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for ophthalmological use; Antibiotic preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of emulsions that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of micelle that facilitate the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Optic preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- EyeCRO LLC, Oklahoma City, OK, US
- EyeCRO LLC, Oklahoma City, OK, US
- EyeCRO LLC, Oklahoma City, OK, US
Prosecution history
- 17 Oct 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Oct 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Oct 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Aug 2026 — TEAS SECTION 8 & 15 RECEIVED
- 06 Oct 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Aug 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 25 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 01 Sept 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Aug 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Aug 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Aug 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED